Pelthos Therapeutics Inc Com (New) Recorded Big Gain

Pelthos Therapeutics Inc Com (New) (PTHS:NYSEMKT) soared at $25.95, representing a gain of 60.3%. On Mon, Jul 07, 2025, PTHS:NYSEMKT hit a New 2-Week High of $25.95. The stock got featured on our News Catalysts scanner on Thu, Jul 03, 2025 at 04:31 AM in the 'MERGER' category. From Mon, Jun 23, 2025, the stock recorded 66.67% Up Days and 50.00% Green Days
The stock spiked on Mon, Jul 07, 2025 at $54.29 with a volume of 1M+.
About Pelthos Therapeutics Inc Com (New) (PTHS:NYSEMKT)
Chromocell Therapeutics Corporation, a clinical-stage biotech company, focuses on the discovery, development, and commercialization of new therapeutics to alleviate pain.
Top 10 Gainers:
- Hempacco Co., Inc. (HPCO:NASDAQ), 250%
- Mustang Bio, Inc. (MBIO:NASDAQ), 180.67%
- LogProstyle Inc. (LGPS:NYSEMKT), 111.97%
- Wolfspeed, Inc. (WOLF:NYSE), 95.76%
- Asset Entities Inc. (ASST:NASDAQ), 63.47%
- Elong Power Holding Limited (ELPW:NASDAQ), 62.71%
- Pelthos Therapeutics Inc Com (New) (PTHS:NYSEMKT), 60.33%
- Viomi Technology Co., Ltd (VIOT:NASDAQ), 59.04%
- Eyenovia, Inc. (EYEN:NASDAQ), 49.81%
- SeaChange International, Inc. (SEAC:NASDAQ), 48.94%